Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-29

Clinical Trial Update: Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oxytocin versus human chorionic gonadotropin as the trigger in ovulation induction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human chorionic gonadotropin (human chorionic gonadotropin)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Shakeela Ishrat | Conditions: Ovulation Induction, Polycystic Ovary Syndrome | Phase 3 | Status: COMPLETED